Aside from data management, there are also devices and other digital tools that (in part) automatically perform glucose measurements and administer insulin.
The conventional way to measure blood glucose levels by finger prick only captures a snapshot in time. This method is gradually being replaced by continuous glucose monitoring (CGM). It tracks glucose levels throughout the day at regular shorter intervals. The readings are then combined and translated into an overall picture and allow continuous monitoring of the metabolism. Another advantage: CGM does not require daily fingerstick tests because a CGM sensor is attached to the abdomen. It transmits the measured levels via a transmitter to a receiver, which can be connected to a smartphone, depending on the device. Some sensors can also be inserted under the skin, making the measurements even more discrete.
Some insulin pump systems can be upgraded to become a CGM system, making the pump the receiver of the sensor's glucose readings without the need for patients to wear any additional equipment on the body. Medtronic's MiniMed 670G is a "hybrid closed loop system", an almost closed insulin delivery system, which is also referred to as an "artificial pancreas." It combines the functions of an insulin pump and a CGM system and measures glucose every five minutes and adjusts insulin delivery based on these readings. What makes it unique is that it automatically stops insulin administration when it reaches a preset low glucose limit, and restarts when levels recover and return to normal.
So-called patch pumps like those offered by OmniPod are simply attached to a body area where the pump administers insulin – without the need for cumbersome tubes. The pump is controlled by the so-called Personal Diabetes Manager (PDM), a small handheld device.